Evidence map›Paper›PMID 33356366›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2021

Is PAD a Hypercoagulable Disorder?

Nathaniel R Smilowitz, Jeffrey S Berger

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Nathaniel R SmilowitzDivision of Cardiology, Department of Medicine, NYU Grossman School of Medicine, New York.
Jeffrey S BergerDivision of Cardiology, Department of Medicine, NYU Grossman School of Medicine, New York.

Funding

Mechanisms of Platelet Activity in Vascular DiseaseR35HL144993 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BERGER, JEFFREY S · 2019 to 2025
$5.5M
Platelet Activity & Cardiovascular Events following Vascular SurgeryR01HL114978 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BERGER, JEFFREY S · 2013 to 2017
$3.0M
NHLBI NIH HHS R01 HL114978NHLBI NIH HHS R35 HL144993
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HemostaticsPeripheral Arterial Diseasevon Willebrand DiseasesFactor VIIIHumansMendelian Randomization AnalysisFactor VIIIHemostaticsblood coagulationEditorialsfactor VIIIMendelian randomization analysisperipheral arterial diseasevascular diseasesvon Willebrand factor

Identifiers

PMID33356366
PMCPMC9911045

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.